Optometrists in Collegeville, PA Accepting Medicare

7 Optometrists found. Showing 1 - 7

Jeffrey Kehr Sole Mbr Optometrist Medicare: Medicare Enrolled Practice Location: 222 E Main St Ste 114, Collegeville Shopping Center, Collegeville, PA 19426 Phone: 610-489-4100    Fax: 610-489-8458

Patricia Siter Dickey, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 555 Second Ave, Collegeville, PA 19426 Phone: 610-489-7800

The Eye Shoppe Optometrist Medicare: Not Enrolled in Medicare Practice Location: 222 E Main St Ste 114, Collegeville Shopping Center, Collegeville, PA 19426 Phone: 610-489-4100

Jennifer A Breunig, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 136 2nd Ave, Collegeville, PA 19426 Phone: 610-489-7800    Fax: 610-489-7988

John Sloat, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 136 Second Avenue, Collegeville, PA 19426 Phone: 610-489-7800    Fax: 610-489-7988

Progressive Family Eyecare And Optique, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 136 Second Ave, Collegeville, PA 19426 Phone: 610-489-7800    Fax: 610-489-7988

Dr. Eric James Neelans, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 222 E Main St Ste 114, Collegeville, PA 19426 Phone: 610-489-4100    Fax: 610-489-8458

News Archive

Researchers develop novel recombinant vaccine against Nipah virus

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis, seizure and coma.

NYT editorial criticizes proposed Medicaid reimbursement rules

Rules proposed by the Bush administration that would reduce Medicaid reimbursements to public hospitals and nursing homes could "have a huge potential impact on an extremely frail population" in states that have enacted laws to "take full advantage" of current rules, a New York Times editorial states (New York Times, 9/10).

Studies in non-human primates provide more predictive results in genetic causes of blindness

Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, as shown by the results of a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

CSL Behring announced today that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery.

Read more Medical News

› Verified 7 days ago